What is the address of PHIL -MED?

The registered office of PHIL -MED is located at Rue du Croiseau 7, 1460 Ittre.

Is PHIL -MED still active?

Yes. According to the CBE (29 October 2026) PHIL -MED is active, legal situation “Normale toestand”, started on 20 October 1997.

Is PHIL -MED registered on Peppol?

Yes, PHIL -MED is registered on the Peppol network with ID 0208:0461707429.

What is the enterprise number of PHIL -MED?

The enterprise number of PHIL -MED is BE0461707429.

When was PHIL -MED founded?

PHIL -MED was founded on 20 October 1997.

Is PHIL -MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 October 1997; 5 annual accounts filed, latest fiscal year 2025; 2 establishments in the CBE.

How much profit did PHIL -MED make in 2025?

PHIL -MED posted a profit after taxes of € 167,212 in financial year 2025.

What is the revenue of PHIL -MED?

As a small company, PHIL -MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 339,863.

PHIL -MED (Private Limited) - Ittre - BE0461707429

Dossier PHIL -MED, printed on 29 October 2026 from databakkes.be/en/0461707429/phil-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHIL -MED from Ittre, company number BE0461707429, closed financial year 2025 with a result of € 167,212 after tax. For that financial year PHIL -MED recorded a gross margin of € 339,863 and equity of € 683,418. Compared with financial year 2024, the result moved from € 145,880 to € 167,212. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 23, 2026.

What it is worth Growing

€ 683,418

▲ 32% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 167,212

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 143,124

▼ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 677,221.

People and assets in 2025

Wage cost

€ 3,629

▼ 20% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 513

▼ 77% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 558,402

▲ 194% vs 2024

€ 312,606 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 5,575

▲ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,779

▼ 55% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 222,980 Gross margin 2022: € 222,980 First fiscal year in the series	€ 199,430 Gross margin 2023: € 199,430 ▼ 11% vs 2022 (€ 222,980) Unfavourable step	€ 284,685 Gross margin 2024: € 284,685 ▲ 43% vs 2023 (€ 199,430) Favourable step	€ 339,863 Gross margin 2025: € 339,863 ▲ 19% vs 2024 (€ 284,685) Favourable step	▲ 19%
Profit after taxes	€ 132,147 Profit after taxes 2022: € 132,147 First fiscal year in the series	€ 101,543 Profit after taxes 2023: € 101,543 ▼ 23% vs 2022 (€ 132,147) Unfavourable step	€ 145,880 Profit after taxes 2024: € 145,880 ▲ 44% vs 2023 (€ 101,543) Favourable step	€ 167,212 Profit after taxes 2025: € 167,212 ▲ 15% vs 2024 (€ 145,880) Favourable step	▲ 15%
Equity	€ 268,784 Equity 2022: € 268,784 First fiscal year in the series	€ 370,327 Equity 2023: € 370,327 ▲ 38% vs 2022 (€ 268,784) Favourable step	€ 516,206 Equity 2024: € 516,206 ▲ 39% vs 2023 (€ 370,327) Favourable step	€ 683,418 Equity 2025: € 683,418 ▲ 32% vs 2024 (€ 516,206) Favourable step	▲ 32%
Total debts	€ 410,704 Total debts 2022: € 410,704 First fiscal year in the series	€ 330,617 Total debts 2023: € 330,617 ▼ 20% vs 2022 (€ 410,704) Favourable step	€ 229,384 Total debts 2024: € 229,384 ▼ 31% vs 2023 (€ 330,617) Favourable step	€ 577,757 Total debts 2025: € 577,757 ▲ 152% vs 2024 (€ 229,384) Unfavourable step	▲ 152%
Cash	€ 139,682 Cash 2022: € 139,682 First fiscal year in the series	€ 186,495 Cash 2023: € 186,495 ▲ 34% vs 2022 (€ 139,682) Favourable step	€ 256,729 Cash 2024: € 256,729 ▲ 38% vs 2023 (€ 186,495) Favourable step	€ 143,124 Cash 2025: € 143,124 ▼ 44% vs 2024 (€ 256,729) Unfavourable step	▼ 44%
Land & buildings	€ 438,227 Land & buildings 2022: € 438,227 First fiscal year in the series	€ 403,441 Land & buildings 2023: € 403,441 ▼ 8% vs 2022 (€ 438,227) Unchanged	€ 393,648 Land & buildings 2024: € 393,648 ▼ 2% vs 2023 (€ 403,441) Unchanged	€ 837,425 Land & buildings 2025: € 837,425 ▲ 113% vs 2024 (€ 393,648) Unchanged	▲ 113%
Retained profit	€ 262,587 Retained profit 2022: € 262,587 First fiscal year in the series	€ 364,129 Retained profit 2023: € 364,129 ▲ 39% vs 2022 (€ 262,587) Favourable step	€ 510,009 Retained profit 2024: € 510,009 ▲ 40% vs 2023 (€ 364,129) Favourable step	€ 677,221 Retained profit 2025: € 677,221 ▲ 33% vs 2024 (€ 510,009) Favourable step	▲ 33%
Bank debt	€ 348,750 Bank debt 2022: € 348,750 First fiscal year in the series	€ 269,890 Bank debt 2023: € 269,890 ▼ 23% vs 2022 (€ 348,750) Favourable step	€ 189,782 Bank debt 2024: € 189,782 ▼ 30% vs 2023 (€ 269,890) Favourable step	€ 558,402 Bank debt 2025: € 558,402 ▲ 194% vs 2024 (€ 189,782) Unfavourable step	▲ 194%
Balance sheet total	€ 679,488 Balance sheet total 2022: € 679,488 First fiscal year in the series	€ 700,943 Balance sheet total 2023: € 700,943 ▲ 3% vs 2022 (€ 679,488) Unchanged	€ 745,590 Balance sheet total 2024: € 745,590 ▲ 6% vs 2023 (€ 700,943) Unchanged	€ 1,261,175 Balance sheet total 2025: € 1,261,175 ▲ 69% vs 2024 (€ 745,590) Unchanged	▲ 69%

Key figures of PHIL -MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHIL -MED?

What happened at PHIL -MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 23, 2026 New annual accounts for financial year 2025: profit of € 167,212 (▲ 15% vs 2024). filed late Source: NBB ↗
Oct 1, 2015 New establishment in Oudergem. KBO
Oct 20, 1997 New establishment in Ittre. KBO
Oct 20, 1997 Start of the company according to the CBE. KBO

In short

From € 132,147 profit in 2022 to € 167,212 profit in 2025.

Paid € 215,849 in corporate taxes since 2022.

Best year ever: 2025, with € 167,212 profit.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Croiseau 7

1460 Ittre

2.306.385.529

Waterleliënlaan 32 box B 3.2

1160 Oudergem

Active since 1 October 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0461.707.429
VAT number: BE 0461.707.429
Registered office: Rue du Croiseau 7, 1460 Ittre
Names & denominations: PHIL -MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 October 1997
Peppol: Active · Active since 14 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

PHIL -MED

Financials

What happened to PHIL -MED?

Establishments

Establishment units

Details

Frequently asked questions